Radiopharmaceuticals and Tracers

The past year saw the release of several new, innovative technologies to improve nuclear imaging in both positron emission tomography (PET) and single-photon emission computed tomography (SPECT). 

Neuraceq, florbetaben, F18, F-18, Piramal, alzheimer's

The U.S. Food and Drug Administration (FDA) has approved a third beta-amyloid plaque positron emission tomography (PET) imaging radiotracer to identify Alzheimer’s disease. The FDA’s approval of Piramal Imaging’s Neuraceq (florbetaben F-18 injecti...

PET vs. SPECT, nuclear imaging advances

Just when positron emission tomography (PET) appears to be eclipsing single photon emission computed tomography (SPECT) for cardiac imaging, new advances make SPECT more attractive. Both modalities also have suffered setbacks with radiopharmaceuti...

September 16, 2014 — Advanced Accelerator Applications (AAA), an international specialist in molecular nuclear medicine, announced this week it has entered...
September 2, 2014 — GE Healthcare announced that the Vizamyl flutemetamol (18F) solution for injection has received marketing authorization from the European...
Kit Lam and colleagues from UC Davis and other institutions have created dynamic nanoparticles (NPs) that could provide an arsenal of applications to diagnose...
August 27, 2014 — Telik Inc., a clinical stage oncology drug development company that merged with MabVax Therapeutics Inc. on July 8, announced it has...
Navidea Biopharmaceuticals’ Lymphoseek (technetium Tc-99m tilmanocept) injection is a radioactive diagnostic imaging agent, approved by the
Siemens Healthcare's syngo.via for molecular imaging is a reading solution that transforms large amounts of data into comprehensive results...
GE Healthcare's Discovery* IQ^ PET/CT (positron emission tomography/computed tomography) system enable both outstanding image quality and...

Articles

June 13, 2014 — The U.S. Food and Drug Administration (FDA) today approved a new use for Navidea Biopharmaceuticals’ Lymphoseek (technetium Tc-99m tilmanocept...
myocardial perfusion, PET/CT, Siemens, Biograph, mCT
The past year saw the release of several new, innovative technologies to improve nuclear imaging in both positron emission tomography (PET) and single-photon...
Neuraceq, florbetaben, F18, F-18, Piramal, alzheimer's
The U.S. Food and Drug Administration (FDA) has approved a third beta-amyloid plaque positron emission tomography (PET) imaging radiotracer to identify...
An international research team at Icahn School of Medicine at Mount Sinai is testing a sugar-based tracer contrast agent to be used with ...

Video Center

As technology continues to advance for all diagnostic imaging modalities, it sometimes reminds me...
2 weeks 20 hours ago
The Society of Cardiovascular Computed Tomography (SCCT) annual meeting July 10-13 in San Diego...
7 weeks 6 days ago
There were several new cardiovascular ultrasound technology advances highlighted at the American...
11 weeks 46 min ago
This webinar explores the role of modern imaging modalities, especially MRI, in all steps of interstitial brachytherapy. It defines the role of imaging in...
This webinar explains more about the breast imaging application available with GE Healthcare's unified Web-based viewer. Available applications and...
The webinar "PET/CT: A New Frontier" discusses potential benefits of digital relative to analog PET/CT. The session will discuss how digital PET can improve...

Comparison Charts

Sorry there is no data available